#DrKKAnswers: Recent advances in the field of intravascular medicine have seen the emergence of drug eluting balloon (DEB) technologies as a viable alternative for treating blocked arterial vessels. Balloon catheter delivers an anti-reblockage drug, such as paclitaxel, at the site of arterial blockage. Within coronary applications, stents are still the ‘gold standard’ but DEBs will have great impact in coronary applications e.g. for the treatment of in-stent restenosis and bifurcation lesions. Furthermore, in combination with bare metal stents they may overcome some of the limitations of DES”.
No comments:
Post a Comment